Apyx Medical (NASDAQ:APYX – Get Free Report) and Regenicin (OTCMKTS:RGIN – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, profitability, analyst recommendations, dividends, valuation, earnings and risk.
Profitability
This table compares Apyx Medical and Regenicin’s net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Apyx Medical | -35.75% | -54.90% | -28.41% |
Regenicin | N/A | N/A | N/A |
Analyst Ratings
This is a summary of recent ratings for Apyx Medical and Regenicin, as reported by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Apyx Medical | 0 | 0 | 2 | 0 | 3.00 |
Regenicin | 0 | 0 | 0 | 0 | N/A |
Institutional and Insider Ownership
55.3% of Apyx Medical shares are held by institutional investors. Comparatively, 0.0% of Regenicin shares are held by institutional investors. 13.1% of Apyx Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.
Valuation and Earnings
This table compares Apyx Medical and Regenicin’s gross revenue, earnings per share (EPS) and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Apyx Medical | $52.35 million | 0.90 | -$18.71 million | ($0.54) | -2.52 |
Regenicin | N/A | N/A | -$640,000.00 | N/A | N/A |
Regenicin has lower revenue, but higher earnings than Apyx Medical.
About Apyx Medical
Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets in the United States and internationally. It operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). The company offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. Its Helium Plasma Technology products are marketed and sold as Renuvion in the cosmetic surgery market and J-Plasma in the hospital surgical market. It also develops and manufactures hand pieces for open and laparoscopic procedures; and OEM generators and related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.
About Regenicin
Regenicin, Inc. focuses on developing and commercializing a technology of tissue-engineered skin substitutes. Its product portfolio includes NovaDerm, a multi-layered tissue-engineered living skin and cultured skin substitute product for the treatment of burns; and TempaDerm to treat smaller wound areas on patients, such as ulcers. The company products are used to restore the qualities of healthy human skin for use in the treatment of burns, chronic wounds, and various plastic surgery procedures. The company was formerly known as Windstar, Inc. and changed its name to Regenicin, Inc. in July 2010. Regenicin, Inc. was incorporated in 2007 and is headquartered in Little Falls, New Jersey.
Receive News & Ratings for Apyx Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Apyx Medical and related companies with MarketBeat.com's FREE daily email newsletter.